ROGER M. PERLMUTTER

Insider Reports History

Location
Millbrae, CA
Signature
/s/ Benjamin Thorner, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ROGER M. PERLMUTTER:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eikon Therapeutics, Inc. Chief Executive Officer and Director, Director Common Stock 1,190,999 04 Feb 2026 Direct
Eikon Therapeutics, Inc. Chief Executive Officer and Director, Director Common Stock 284,857 06 Feb 2026 Indirect
Eikon Therapeutics, Inc. Chief Executive Officer and Director, Director Series A-1 Preferred Stock 0 06 Feb 2026 Indirect
Eikon Therapeutics, Inc. Chief Executive Officer and Director, Director Series D Preferred Stock 0 06 Feb 2026 Indirect
NGM BIOPHARMACEUTICALS INC Director Stock Option (Right to Buy) 0 05 Apr 2024 Direct

Insider Reports Filed by ROGER M. PERLMUTTER

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EIKN Eikon Therapeutics, Inc. 06 Feb 2026 3 $0 4 Chief Executive Officer and Director, Director 10 Feb 2026, 17:06
EIKN Eikon Therapeutics, Inc. 04 Feb 2026 0 $0 3 Chief Executive Officer and Director Exhibit List - Exhibit 24 - Power of Attorney, Director 04 Feb 2026, 21:21
/report/000095017024042588-perlmutter-roger-m-2024-04-05 NGM BIOPHARMACEUTICALS INC 05 Apr 2024 3 $0 4 Director 08 Apr 2024, 16:09
/report/000120919123029183-perlmutter-roger-m-2023-05-10 NGM BIOPHARMACEUTICALS INC 10 May 2023 1 $0 4 Director 12 May 2023, 17:49
/report/000120919122031135-perlmutter-roger-m-2022-05-18 NGM BIOPHARMACEUTICALS INC 18 May 2022 1 $0 4 Director 20 May 2022, 18:24
/report/000120919121039585-perlmutter-roger-m-2021-06-08 NGM BIOPHARMACEUTICALS INC 08 Jun 2021 1 $0 4 Director 10 Jun 2021, 17:34
/report/000120919121039582-perlmutter-roger-m-2021-06-08 NGM BIOPHARMACEUTICALS INC 08 Jun 2021 0 $0 3 Director 10 Jun 2021, 17:33